# DESCRIPTION

## INTRODUCTION

- describe multiple myeloma
- motivate targeted sequencing

## SUMMARY

- introduce capture-based sequencing approach
- describe advantages over existing methods
- motivate personalized treatment plans
- design oligonucleotide probes
- outline methods for identifying multiple myeloma mutations
- list genes mutated in multiple myeloma
- describe oligonucleotide probes for various gene regions
- define DNA capture array
- describe oligonucleotide probes
- specify target genes
- provide variations of gene numbers

## DETAILED DESCRIPTION

- introduce DNA capture array
- describe method of identifying multiple myeloma mutations
- outline advantages of array-based method
- describe analysis of tumor mutations
- outline methods for determining mutual exclusivity/co-occurrence
- mention integrative analysis

### DETAILED DESCRIPTION

- design custom capture sequencing platform
- perform capture sequencing of 95 tumor/normal pairs
- perform deep capture sequencing of 15 tumor/normal pairs
- calculate sequencing coverage
- detect copy number variants using capture sequencing data
- detect CNVs using CopyCAT2
- annotate CNVs with gene information
- detect translocations using LUMPY
- filter translocations using machine learning approach
- map IGH constant, switch, and enhancer regions
- validate novel t(14,22) translocation
- perform PCR on genomic DNA
- validate novel t(13;14) translocation
- detect somatic single nucleotide variants
- compare initial capture and subsequent deep sequencing
- explore effect of varying read depth on variant discovery
- compare capture sequencing to exome sequencing

## EXAMPLES

- illustrate design and application of oligonucleotide probe array for targeted sequence capture

### Example 1

- design oligonucleotide probes for MM-specific custom capture sequencing platform

### Example 2

- sequence 95 paired tumor and normal cell DNA samples using the platform

### Example 3

- identify copy number alterations with prognostic significance using targeted capture sequencing

### Example 4

- detect IGH translocations using LUMPY and filtering strategy

### Example 5

- prioritize novel IGH translocations as potential driver mutations
- validate IGLL5 translocation and co-incident over-expression of DERL3 in MM

### Example 6

- detect intra- and inter-chromosomal MYC translocations using machine learning-based approach

### Example 7

- identify non-silent single nucleotide variants in all tumor samples

### Example 8

- determine whether increased sequencing depth yields few additional variants

### Example 9

- facilitate integrative analysis across mutation types
- highlight patterns of mutual exclusivity and co-occurrence within and across mutation types

